Drug Profile
MK 1376
Latest Information Update: 19 Apr 2016
Price :
$50
*
At a glance
- Originator Merck & Co
- Class Antivirals
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported HIV infections